NTLA

NTLA Net Receivables

$7.32MQuarterly · USD

Period ending:

NTLA FY Net ReceivablesUSD
NTLA FY Net Receivables2014-12-31: $0.002015-12-31: $1.00M2016-12-31: $6.45M2017-12-31: $10.47M2018-12-31: $7.55M2019-12-31: $4.62M2020-12-31: $2.13M2021-12-31: $2.03M2022-12-31: $3.77M2023-12-31: $36.46M2024-12-31: $8.52M2025-12-31: $9.47M$36.46M$0.00
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NTLA net receivables history

Net amount expected from customer receivables. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Intellia Therapeutics Inc Net Receivables — Annual fiscal periods (USD)
Period endingNet Receivables (USD)
9,468,000
8,517,000
36,456,000
3,768,000
2,031,000
2,130,000
4,620,000
7,547,000
10,471,000
6,454,000
1,000,000
0

Compare net receivables

All NTLA financial metrics · NTLA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.